ENvue Medical, Inc. (FEED) Stock

ENvue Medical, Inc. (FEED) is a Healthcare stock trading at $0.42 (as of 2026-07-16), with a market capitalization of $4.71M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

NanoVibronix, Inc. develops noninvasive devices intended to activate biological responses, including UroShield and PainShield. The company operates in the United States, Europe, Australia, India, Israel, and other regions.

Understand ENvue Medical, Inc.: how it makes money

ENvue Medical develops noninvasive biological response-activating medical device products, including UroShield and PainShield, and operates across multiple geographic markets.

With gross margin of -8.4% and operating margin of -568.3% in the latest reported period, the profit model depends on whether ENvue can commercialize its device products at economics strong enough to cover operating costs.

Business quality (Weak): Clear product focus (UroShield, PainShield) and a defined device approach, but the latest reported margins show losses at both gross and operating levels, and there is no provided segment revenue or operating KPI to gauge underlying drivers.

Bull case

  • Focused device platform: The company develops noninvasive biological response-activating devices, with named products including UroShield and PainShield.
  • Multi-market footprint: The company reports geographic operations including the United States, Europe, Australia, India, Israel, and Other.

Bear case

  • Unprofitable economics in the latest period: For 2026-03-31, gross margin was -8.4% and operating margin was -568.3%, indicating losses before and after operating expenses.
  • Limited disclosed operating indicators: No operational KPI candidates were provided, making it harder for investors to track the day-to-day drivers of improvement or deterioration.
Valuation — source: SEC EDGAR (first-party)
Price$0.42
Market Cap$4.71M
Price / Book0.15
Price / Sales2.44
FCF Yield-249.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.55M
Net Margin-712.3%
Revenue Growth (YoY)-51.6%
EPS Growth (YoY)92.2%
FCF Growth (YoY)-19.8%
Financial Health — source: SEC EDGAR
Altman Z-Score-4.71 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderGEODE CAPITAL MANAGEMENT, LLC ($53352.00)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEODoron Robert Besser
Employees31
CountryUS
IPO Date2025-12-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
  • HeartSciences Inc. (HSCS)
  • CollPlant Biotechnologies Ltd. (CLGN)
  • Catheter Precision, Inc. (VTAK)
  • Sonoma Pharmaceuticals, Inc. (SNOA)
  • Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD)
  • INVO Fertility, Inc. (IVF)
  • Bone Biologics Corporation (BBLG)
FEED earnings history · FEED institutional & insider holders · FEED KPIs & operating metrics · FEED financials · FEED investor presentations & press releases · FEED SEC filings · FEED peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-16.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.